Guillaume Roberge

Roberge G, Carrier M

Long VITT: A case report

Thromb Res, 223 , 2023.

Résumé | Liens:

Ducharme-Bénard S, Roberge G, Chapdelaine H

A unique presentation of NLRP3-associated autoinflammatory disease: case report

BMC Rheumatol, 6 (1), 2022.

Résumé | Liens:

Roberge G, Côté B, Calabrino A, Gilbert N, Gagnon N

Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases

Thromb J, 20 (1), 2022.

Résumé | Liens:

Roberge G, Carrier M

Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia

Clin Appl Thromb Hemost, 28 , 2022.

| Liens:

Roberge G, Delluc A

Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer

Thromb Res, 197 , 2021.

Résumé | Liens:

Roberge G, Wells PS

Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report

Thromb J, 19 (1), 2021.

Résumé | Liens:

Patriquin CJ, Laroche V, Selby R, Pendergrast J, Barth D, Côté B, Gagnon N, Roberge G, Carrier M, Castellucci LA, Scarvelis D, Mack JP

Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia

N Engl J Med, 385 (9), 2021.

| Liens:

Roberge G, D'Astous J, Rodger M

Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT): COMMENT from Roberge, et al

J Thromb Haemost, 19 (8), 2021.

| Liens:

Roberge G

May-Thurner syndrome prevalence as a risk factor for acute deep vein thrombosis is unknown

J Thromb Haemost, 19 (8), 2021.

| Liens:

Roberge G, Tritschler T, MacGillivray C, Dufresne L, Nagpal SK, Scarvelis D

Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report

J Thromb Thrombolysis, 50 (3), 2020.

Résumé | Liens: